Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes
Bloodwork matters
Furthermore, we emphasize the translational potential of Kla as a diagnostic or prognostic biomarker and therapeutic target, offering novel insights for future research and development of innovative therapeutic strategies
Ongoing confusion and concern, not just in patients, but also in many doctors regarding potential statin side effects, mean that many people are not willing to start statins, or have stopped them, even if theyre at high risk of having either a first or recurrent heart attack or stroke and may derive really significant benefit from them, said Christina Reith, associate professor at Oxford Population Health and lead author of the study
Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial